Published in World J Diabetes on May 15, 2010
Protective effect of magnesium on renal function in STZ-induced diabetic rats. J Diabetes Metab Disord (2014) 0.81
Diagnostic value of the combined measurement of serum hcy, serum cys C, and urinary microalbumin in type 2 diabetes mellitus with early complicating diabetic nephropathy. ISRN Endocrinol (2013) 0.80
Elevated brachial-ankle pulse wave velocity is independently associated with microalbuminuria in a rural population. J Korean Med Sci (2014) 0.78
Does glimepiride alter the pharmacokinetics of sildenafil citrate in diabetic nephropathy animals: investigating mechanism of interaction by molecular modeling studies. J Mol Model (2015) 0.78
Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy. Inflammation (2016) 0.78
Potential of Dietary Non-Provitamin A Carotenoids in the Prevention and Treatment of Diabetic Microvascular Complications. Adv Nutr (2016) 0.76
Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy. Can J Kidney Health Dis (2017) 0.76
Vitamin D Modulates Hematological Parameters and Cell Migration into Peritoneal and Pulmonary Cavities in Alloxan-Diabetic Mice. Biomed Res Int (2017) 0.75
Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients. World J Diabetes (2017) 0.75
Assessment of microalbuminuria and albumin creatinine ratio in patients with type 2 diabetes mellitus. J Nat Sci Biol Med (2015) 0.75
Preventive effects of betulinic acid on streptozotocinnicotinamide induced diabetic nephropathy in male mouse. J Nephropathol (2016) 0.75
Protective Effects of MDG-1, a Polysaccharide from Ophiopogon japonicus on Diabetic Nephropathy in Diabetic KKA(y) Mice. Int J Mol Sci (2015) 0.75
Cryptolepine, an indoloquinoline alkaloid, in the management of diabetes mellitus and its associated complications. J Intercult Ethnopharmacol (2016) 0.75
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care (1998) 24.53
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition (1992) 16.89
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med (2003) 13.84
Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med (2004) 11.52
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03
Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis (2002) 6.52
Standards of medical care in diabetes. Diabetes Care (2005) 5.98
Blood pressure and end-stage renal disease in men. N Engl J Med (1996) 5.68
Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res (2007) 5.48
Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol (2004) 5.29
CCN proteins: multifunctional signalling regulators. Lancet (2004) 4.88
Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int (2006) 4.59
Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57
Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis (2000) 4.44
Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest (1985) 4.38
Cystatin C as a marker of GFR--history, indications, and future research. Clin Biochem (2005) 3.10
Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care (2006) 3.00
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension (2005) 2.69
Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int (2008) 2.47
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol (2002) 2.46
The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int (2003) 2.43
Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol (2000) 1.93
Hypertension, angiotensin II, and oxidative stress. N Engl J Med (2002) 1.92
Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol (2000) 1.76
Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant (2002) 1.74
Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol (2005) 1.74
Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care (2008) 1.67
Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes (1997) 1.59
Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol (2004) 1.56
Validity of rapid estimation of glomerular filtration rate in type 2 diabetic patients with normal renal function. Nephrol Dial Transplant (1999) 1.51
Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study. Kidney Int Suppl (2004) 1.50
Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia (2006) 1.42
Epidemiology of diabetes in India--three decades of research. J Assoc Physicians India (2005) 1.42
Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care (2002) 1.39
Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy. Diabetes Care (2006) 1.37
Central obesity is an independent risk factor for albuminuria in nondiabetic South Asian subjects. Diabetes Care (2007) 1.36
Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J (1992) 1.35
Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev (1989) 1.35
Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest (1998) 1.33
Lower serum creatinine is a new risk factor of type 2 diabetes: the Kansai healthcare study. Diabetes Care (2008) 1.32
A urinary and plasma alpha1-glycoprotein of low molecular weight: isolation and some properties. Biochem Biophys Res Commun (1975) 1.25
Tubular and glomerular injury in diabetes and the impact of ACE inhibition. Diabetes Care (2009) 1.23
Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diabetes Care (2006) 1.20
Retinol, alpha-tocopherol and carotenoids in diabetes. Eur J Clin Nutr (1999) 1.18
Socio-economic burden of diabetes in India. J Assoc Physicians India (2007) 1.18
Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy. Diabetes Care (2008) 1.18
Complications and cardiovascular risk factors in South Asians and Europeans with early-onset type 2 diabetes. QJM (2002) 1.17
South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients. Diabetes Care (2006) 1.16
Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels. Diabetes (2008) 1.16
Cockcroft-Gault formula is biased by body weight in diabetic patients with renal impairment. Metabolism (2006) 1.14
Adiponectin, an adipocyte-derived protein. Physiol Res (2005) 1.10
Role for GLUT1 in diabetic glomerulosclerosis. Expert Rev Mol Med (2006) 1.01
Renal function--estimation of glomerular filtration rate. Clin Chem Lab Med (2006) 1.00
Urinary alpha1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore. Diabetes Care (2003) 0.99
Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabetes Care (2007) 0.94
Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes. Diabetes Care (2000) 0.90
Clinical significance of urinary liver-type fatty acid-binding protein in patients with diabetic nephropathy. Diabetes Care (2005) 0.88
Influence of body weight on the performance of glomerular filtration rate estimators in subjects with type 2 diabetes. Diabetes Care (2007) 0.88
Minor renal dysfunction: an emerging independent cardiovascular risk factor. Heart (2003) 0.86
Microproteinuria in type 2 diabetes mellitus from diagnosis. Diabet Med (1990) 0.83
Early diabetes-related complications in adolescents: risk factors and screening. Horm Res (2005) 0.83
Diabetic nephropathy. Diabetes Care (2008) 0.82
Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy. Am J Nephrol (1998) 0.81
[Urinary proteins in patients with diabetes mellitus]. Klin Wochenschr (1989) 0.76